<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Utility of Pancreas Surface Lobularity as a CT Biomarker for Opportunistic Screening of Type 2 Diabetes - Health AI Hub</title>
    <meta name="description" content="This pilot study introduces an automated deep learning-based approach to identify Pancreatic Surface Lobularity (PSL) from CT scans as a novel biomarker for opp">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Utility of Pancreas Surface Lobularity as a CT Biomarker for Opportunistic Screening of Type 2 Diabetes</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.10484v1" target="_blank">2511.10484v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-13
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Tejas Sudharshan Mathai, Anisa V. Prasad, Xinya Wang, Praveen T. S. Balamuralikrishna, Yan Zhuang, Abhinav Suri, Jianfei Liu, Perry J. Pickhardt, Ronald M. Summers
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.10484v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.10484v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This pilot study introduces an automated deep learning-based approach to identify Pancreatic Surface Lobularity (PSL) from CT scans as a novel biomarker for opportunistic screening of Type 2 Diabetes Mellitus (T2DM). The research demonstrates that diabetic patients exhibit significantly higher PSL compared to non-diabetic individuals, and a multivariate model incorporating CT biomarkers can effectively screen for T2DM with high accuracy.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research offers a novel, non-invasive method for opportunistic T2DM screening by leveraging routinely acquired CT scans. Identifying T2DM or at-risk individuals earlier through this biomarker could lead to timely interventions, potentially preventing or delaying severe complications and improving long-term patient outcomes.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application involves using deep learning models for automated segmentation of the pancreas and other abdominal structures from CT scans, and for the automatic detection and quantification of pancreas surface lobularity (PSL). This AI-derived biomarker is then used in a multivariate model to predict the presence and potential early onset of Type 2 Diabetes Mellitus, enabling opportunistic screening within a healthcare context.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>The study investigates Pancreatic Surface Lobularity (PSL) as a novel CT imaging biomarker for Type 2 Diabetes Mellitus (T2DM), distinguishing it from previously studied pancreas volume and fat content.</li>
                    
                    <li>A fully automated deep learning pipeline was developed to delineate the pancreas and other abdominal structures from CT scans, utilizing four distinct deep learning models.</li>
                    
                    <li>The PancAP model achieved the highest performance for pancreas segmentation, with a Dice score of 0.79 ¬± 0.17 and an Average Symmetric Surface Distance (ASSD) error of 1.94 ¬± 2.63 mm (p<0.05).</li>
                    
                    <li>Automated PSL detection revealed significantly higher lobularity in diabetic patients (4.26 ¬± 8.32) compared to non-diabetic patients (3.19 ¬± 3.62, p=0.01).</li>
                    
                    <li>A multivariate model trained with CT biomarkers for T2DM prediction achieved strong classification performance, with an Area Under the Curve (AUC) of 0.90, 66.7% sensitivity, and 91.9% specificity.</li>
                    
                    <li>The findings suggest that PSL is a useful biomarker for opportunistic T2DM screening, potentially enabling early detection and intervention.</li>
                    
                    <li>The study was conducted on an internal dataset of 584 patients (297 males, 437 non-diabetic, age: 45¬±15 years).</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study employed a fully automated approach beginning with the segmentation of the pancreas and other abdominal structures from CT images using four deep learning-based models. This segmentation was performed on an internal dataset of 584 patients. Following segmentation, Pancreatic Surface Lobularity (PSL) was automatically detected and derived as an imaging biomarker. The PSL values were then statistically compared between diabetic and non-diabetic patient groups. Finally, a multivariate model, trained with derived CT biomarkers, was used to predict the presence of T2DM, with its performance evaluated using metrics like AUC, sensitivity, and specificity.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>Pancreatic Surface Lobularity (PSL) was significantly higher in diabetic patients (4.26 ¬± 8.32) compared to non-diabetic patients (3.19 ¬± 3.62, p=0.01). Among the deep learning models tested for pancreas segmentation, the PancAP model demonstrated superior performance, achieving a Dice score of 0.79 ¬± 0.17 and an Average Symmetric Surface Distance (ASSD) error of 1.94 ¬± 2.63 mm (p<0.05). A multivariate model built with CT biomarkers successfully predicted T2DM with an AUC of 0.90, 66.7% sensitivity, and 91.9% specificity.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This research provides a valuable tool for opportunistic T2DM screening that can be integrated into existing clinical workflows without requiring additional patient procedures or dedicated scans. By automatically analyzing CT scans, it offers a scalable, non-invasive method to identify individuals with T2DM or those at risk. This early detection capability could facilitate earlier lifestyle modifications, pharmacological interventions, and monitoring, potentially mitigating disease progression and its associated complications, thereby improving public health outcomes.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract explicitly notes this as "pilot work," indicating the preliminary nature of the findings. The study utilized an internal dataset of 584 patients, which might limit the generalizability of the results to broader, more diverse populations or different CT scanner protocols. Further validation on larger, external datasets is necessary to confirm the robustness and wider applicability of the proposed biomarker and predictive model.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The findings suggest that PSL could potentially help predict the early onset of T2DM, indicating a future direction for longitudinal studies to evaluate its utility in identifying pre-diabetic states or predicting future T2DM development. Further research should focus on validating these results in larger, more diverse patient cohorts and across different medical centers to ensure generalizability. Investigation into the specific biological mechanisms underlying increased pancreatic surface lobularity in T2DM would also be beneficial.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Endocrinology</span>
                    
                    <span class="tag">Radiology</span>
                    
                    <span class="tag">Diabetology</span>
                    
                    <span class="tag">Preventive Medicine</span>
                    
                    <span class="tag">Medical Artificial Intelligence</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Type 2 Diabetes Mellitus</span>
                    
                    <span class="tag tag-keyword">Pancreatic Surface Lobularity</span>
                    
                    <span class="tag tag-keyword">CT Biomarker</span>
                    
                    <span class="tag tag-keyword">Deep Learning</span>
                    
                    <span class="tag tag-keyword">Opportunistic Screening</span>
                    
                    <span class="tag tag-keyword">Pancreas Segmentation</span>
                    
                    <span class="tag tag-keyword">Medical Imaging</span>
                    
                    <span class="tag tag-keyword">Early Detection</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disease that affects millions of people worldwide. Early detection is crucial as it can alter pancreas function through morphological changes and increased deposition of ectopic fat, eventually leading to organ damage. While studies have shown an association between T2DM and pancreas volume and fat content, the role of increased pancreatic surface lobularity (PSL) in patients with T2DM has not been fully investigated. In this pilot work, we propose a fully automated approach to delineate the pancreas and other abdominal structures, derive CT imaging biomarkers, and opportunistically screen for T2DM. Four deep learning-based models were used to segment the pancreas in an internal dataset of 584 patients (297 males, 437 non-diabetic, age: 45$\pm$15 years). PSL was automatically detected and it was higher for diabetic patients (p=0.01) at 4.26 $\pm$ 8.32 compared to 3.19 $\pm$ 3.62 for non-diabetic patients. The PancAP model achieved the highest Dice score of 0.79 $\pm$ 0.17 and lowest ASSD error of 1.94 $\pm$ 2.63 mm (p$<$0.05). For predicting T2DM, a multivariate model trained with CT biomarkers attained 0.90 AUC, 66.7\% sensitivity, and 91.9\% specificity. Our results suggest that PSL is useful for T2DM screening and could potentially help predict the early onset of T2DM.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>Submitted to IEEE ISBI 2026</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>